Marathon Pharmaceuticals is a company that specializes in developing as well as launching brand new treatments of diseases that are quite rare in nature. They are focused on hard-to manufacture medications and make them available to their patients with limited treatment options. They are also investigating numerous treatments for neurological disorders, rare cancers, and other ailments too.
Marathon Pharmaceuticals has offices in New Jersey and is headquartered in Northbrook, Illinois. Their Chicago facility is used to find new therapies for central nervous system diseases, cancer, endocrine deficiencies, and gastrointestinal diseases. Their Bioscience Center is located in close proximity to MATTER which is a hub for healthcare start-ups and biotechnology.
Marathon Pharmaceuticals is able to manufacture medications such as Amytal Sodium which can be difficult to manufacture. Amytal Sodium is a barbiturate derivative that is a sedative hypnotic. It is used to decrease motor activity and is also effective in producing drowsiness, sedation, and hypnosis. It is a short-term treatment for insomnia. They also manufacture Amytal Sodium which is another type of barbiturate derivative. It is used as a pre-anesthetic before a surgery.
PEPCID® is another product that they manufacture, and it is used to reduce stomach acid in patients. It is also a short-term treatment of ulcers and gastroesophageal reflux disease. They are well known for launching ZINGO which is a powder intradermal injection system. It is used primarily by children between the ages of three and 13 who have a difficult time with needle insertions.
In order to distribute ZINGO, Marathon Pharmaceuticals has joined forces with Medline. Medline is a global distributor of clinical solutions as well as medical supplies. According to Luke Stevens, President of the Nutrition and Pharmaceuticals Division of Medline, the collaboration has made it possible for the best in the healthcare industry to become more focused on patient care.
The companies are working on the same wavelength and will now be able to deliver ZINGO to patients who need it. They’ll be able to keep up with the demand for the product and ZINGO will be brought to medical centers, children’s hospitals, and community hospitals.